- Deltex Medical said per-tax losses narrowed to £2.1m in the year to the end of December, from a loss of £2.5m the previous year supported by improved margins and lower costs.

Group revenues fell by £0.4m to £5.9m in 2017 from £6.3m the previous year as poor performance in the second half of the year weighed on sales.

'Second half sales were disappointing with weak trends in the UK exacerbated by delays in a number of expected developments across all parts of the business,' the firm said.

Gross margins improved to 75% from 68%.

Poor second half sales seen last year continued into 2018 as the firm said first-quarter revenues were held back by expected timing differences on monitor sales. This had affected year-on-year growth in all three sales operations in April including UK probe revenues.

At 10:00am: [LON:DEMG] Deltex Medical Group PLC share price was -0.18p at 1.23p

Story provided by